In last trading session, Monte Rosa Therapeutics Inc (NASDAQ:GLUE) saw 0.53 million shares changing hands with its beta currently measuring 1.46. Company’s recent per share price level of $6.22 trading at -$0.41 or -6.18% at ring of the bell on the day assigns it a market valuation of $382.14M. That closing price of GLUE’s stock is at a discount of -99.36% from its 52-week high price of $12.40 and is indicating a premium of 48.39% from its 52-week low price of $3.21.
For Monte Rosa Therapeutics Inc (GLUE), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.29. Splitting up the data highlights that, out of 5 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 4 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0.11 in the current quarter.
Monte Rosa Therapeutics Inc (NASDAQ:GLUE) trade information
Upright in the red during last session for losing -6.18%, in the last five days GLUE remained trading in the red while hitting it’s week-highest on Tuesday, 02/18/25 when the stock touched $6.22 price level, adding 13.85% to its value on the day. Monte Rosa Therapeutics Inc’s shares saw a change of -10.37% in year-to-date performance and have moved -7.44% in past 5-day. Monte Rosa Therapeutics Inc (NASDAQ:GLUE) showed a performance of 12.48% in past 30-days.
7 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 51.19M for the same. And 5 analysts are in estimates of company making revenue of 5.88M in the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -96.71% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 61.74% while estimates for its earnings growth in next 5 years are of 9.42%.
Monte Rosa Therapeutics Inc (NASDAQ:GLUE)’s Major holders
NEA MANAGEMENT COMPANY, LLC is the top institutional holder at GLUE for having 7.69 million shares of worth $28.77 million. And as of 2024-06-30, it was holding 10.7986 of the company’s outstanding shares.
The second largest institutional holder is PRICE T ROWE ASSOCIATES INC /MD/, which was holding about 5.98 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.9368 of outstanding shares, having a total worth of $22.36 million.
On the other hand, Price (T.Rowe) New Horizons Fund and Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 3.41 shares of worth $21.19 million or 5.54% of the total outstanding shares. The later fund manager was in possession of 1.35 shares on Sep 30, 2024 , making its stake of worth around $8.4 million in the company or a holder of 2.20% of company’s stock.
